Orca Capital AG 13D and 13G filings for Lixte Biotechnology Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-18 4:15 pm Sale |
2025-02-14 | 13G | Lixte Biotechnology Holdings, Inc. LIXT |
Orca Capital AG | 120,012 4.500% |
-97,380 (-44.79%) |
Filing |
| 2025-02-13 4:48 pm Purchase |
2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT |
Orca Capital AG | 217,392 8.100% |
217,392 (New Position) |
Filing |